Literature DB >> 2550676

Direct isolation and characterization of JC virus from urine samples of renal and bone marrow transplant patients.

C Myers1, R J Frisque, R R Arthur.   

Abstract

JC virus DNA was extracted from urine-derived cells of bone marrow and renal transplant patients and cloned directly into the plasmid vector pBR322. These clones represent the first JC virus isolates obtained directly from individuals that did not have progressive multifocal leukoencephalopathy (PML). Three of the clones appeared to be identical to the prototype JC virus Mad 1, and the fourth clone was identical to the type II JC virus variant Mad8-Br. Importantly, the same JC virus strains have been identified both in the urine of non-PML patients and in the brain tissue of PML patients. These results indicate that different organs may be infected with the same JC virus subtype and implies that an adaptation process involving the alteration of viral regulatory signals is not required in the pathogenesis of PML. Furthermore, both a type I and a type II variant were obtained from the same patient, suggesting that an individual may be infected with more than one strain of JC virus at a given time.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550676      PMCID: PMC251067          DOI: 10.1128/JVI.63.10.4445-4449.1989

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  36 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  S A Houff; E O Major; D A Katz; C V Kufta; J L Sever; S Pittaluga; J R Roberts; J Gitt; N Saini; W Lux
Journal:  N Engl J Med       Date:  1988-02-04       Impact factor: 91.245

3.  Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy.

Authors:  B L Padgett; D L Walker
Journal:  J Infect Dis       Date:  1973-04       Impact factor: 5.226

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Regulation of the host range of human papovavirus JCV.

Authors:  L Feigenbaum; K Khalili; E Major; G Khoury
Journal:  Proc Natl Acad Sci U S A       Date:  1987-06       Impact factor: 11.205

6.  Construction and characterization of hybrid polyomavirus genomes.

Authors:  W F Chuke; D L Walker; L B Peitzman; R J Frisque
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

7.  BK and JC virus infections in recipients of bone marrow transplants.

Authors:  R R Arthur; K V Shah; P Charache; R Saral
Journal:  J Infect Dis       Date:  1988-09       Impact factor: 5.226

8.  DNA rearrangements in organ-specific variants of polyomavirus JC strain GS.

Authors:  G Loeber; K Dörries
Journal:  J Virol       Date:  1988-05       Impact factor: 5.103

9.  Direct detection of the human papovavirus BK in urine of bone marrow transplant recipients: comparison of DNA hybridization with ELISA.

Authors:  R R Arthur; A M Beckmann; C C Li; R Saral; K V Shah
Journal:  J Med Virol       Date:  1985-05       Impact factor: 2.327

10.  Discrete elements within the SV40 enhancer region display different cell-specific enhancer activities.

Authors:  B Ondek; A Shepard; W Herr
Journal:  EMBO J       Date:  1987-04       Impact factor: 11.598

View more
  19 in total

1.  BK virus and JC virus shed during pregnancy have predominantly archetypal regulatory regions.

Authors:  R B Markowitz; B A Eaton; M F Kubik; D Latorra; J A McGregor; W S Dynan
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Enhancer/promoter activities of regulatory regions of representative JC virus isolates.

Authors:  J D Martin; P Li
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Sequence rearrangement in JC virus DNAs molecularly cloned from immunosuppressed renal transplant patients.

Authors:  Y Yogo; T Kitamura; C Sugimoto; K Hara; T Iida; F Taguchi; A Tajima; K Kawabe; Y Aso
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

4.  High incidence of JC viruria in JC-seropositive older individuals.

Authors:  Han Chang; Meilin Wang; Rong-Tai Tsai; Hui-Sheng Lin; Jin-Shue Huan; Wen-Chuang Wang; Deching Chang
Journal:  J Neurovirol       Date:  2002-10       Impact factor: 2.643

5.  Detection of human immunodeficiency virus type 1 (HIV-1) in urine cell pellets from HIV-1-seropositive individuals.

Authors:  J J Li; Y Q Huang; B J Poiesz; L Zaumetzger-Abbot; A E Friedman-Kien
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

6.  Typing of human polyomavirus JC virus on the basis of restriction fragment length polymorphisms.

Authors:  Y Yogo; T Iida; F Taguchi; T Kitamura; Y Aso
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

Review 7.  Pathogenesis of progressive multifocal leukoencephalopathy--revisited.

Authors:  Martyn K White; Kamel Khalili
Journal:  J Infect Dis       Date:  2011-01-12       Impact factor: 5.226

8.  Transcription of the JC virus archetype late genome: importance of the kappa B and the 23-base-pair motifs in late promoter activity in glial cells.

Authors:  R P Mayreddy; M Safak; M Razmara; P Zoltick; K Khalili
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

9.  Detection of BK virus DNA in nasopharyngeal aspirates from children with respiratory infections but not in saliva from immunodeficient and immunocompetent adult patients.

Authors:  A Sundsfjord; A R Spein; E Lucht; T Flaegstad; O M Seternes; T Traavik
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

10.  JC virus DNA is present in many human brain samples from patients without progressive multifocal leukoencephalopathy.

Authors:  F A White; M Ishaq; G L Stoner; R J Frisque
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.